# A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients

> **NCT00000699** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 20 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Inosine pranobex
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT00000699
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000699, "A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00000699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*